Richard A Meier Biomarin Pharmaceutical Inc (BMRN) insider trading activity

Richard A Meier is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 127,426 shares of BMRN, which is worth approximately $7.4 Million. The most recent transaction as insider was on May 20, 2025, when has been sold 6,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 127K

5.51% 3M change

6.52% 12M change

Total Value Held $7.4 Million

RICHARD A MEIER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	BUY Grant, award, or other acquisition	-	6,650 Added 4.96%	127,426 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$416,510 $76.41 p/Share	5,451 Reduced 4.32%	120,776 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$416,460 $63.1 p/Share	6,600 Added 4.97%	126,227 Common Stock
May 21 2024	BUY Grant, award, or other acquisition	-	7,080 Added 5.59%	119,627 Common Stock
Jan 08 2024	SELL Bona fide gift	-	3,000 Reduced 2.6%	112,547 Common Stock
May 23 2023	BUY Grant, award, or other acquisition	-	4,190 Added 3.5%	115,547 Common Stock
May 12 2023	SELL Payment of exercise price or tax liability	$576,448 $93.93 p/Share	6,137 Reduced 5.22%	111,357 Common Stock
May 12 2023	BUY Exercise of conversion of derivative security	$576,385 $67.81 p/Share	8,500 Added 6.75%	117,494 Common Stock
May 24 2022	BUY Grant, award, or other acquisition	-	4,980 Added 4.37%	108,994 Common Stock
May 02 2022	SELL Open market or private sale	$318,384 $82.1 p/Share	3,878 Reduced 3.59%	104,014 Common Stock
May 02 2022	BUY Exercise of conversion of derivative security	$318,410 $37.46 p/Share	8,500 Added 7.3%	107,892 Common Stock
May 25 2021	BUY Grant, award, or other acquisition	-	5,120 Added 4.9%	99,392 Common Stock
May 06 2021	SELL Open market or private sale	$397,230 $78.38 p/Share	5,068 Reduced 5.1%	94,272 Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	$397,350 $26.49 p/Share	15,000 Added 13.12%	99,340 Common Stock

Also insider at

RKLY

Rockley Photonics Holdings Ltd Technology

President & CFO

RAM

Richard A Meier

Director

Novato, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Value

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN

Account